The report outlines KELUN PHARMA's achievements in environmental protection, social responsibility, and corporate governance in 2023. The company has been actively responding to national calls and promoting sustainable development, with notable highlights including the adoption of a circular economy model in production, investment in R&D, and a commitment to fair pricing for medical products in developing countries. The report also showcases the company's efforts in talent cultivation and development, establishing an inclusive work environment, and promoting employee wellbeing.
Issuing Company Sichuan Kelun Pharmaceutical Co., Ltd.
Report Type Sustainability Report
Report Language EN
Report Filesize 7.56 MB
No. of Pages 112 pages
Reporting periodJanuary 1, 2023-December 31, 2023
Report Edition12
Assurance Provider Unknown
Reporting Standards GRI; UN SDGs; Morgan Stanley International ESG ratings
Materiality Assessmenttrue